Cargando…
Comparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasis
BACKGROUND: The development of an effective vaccine against visceral leishmaniasis (VL) caused by Leishmania donovani is an essential aim for controlling the disease. Use of the right adjuvant is of fundamental importance in vaccine formulations for generation of effective cell-mediated immune respo...
Autores principales: | Ravindran, Rajesh, Bhowmick, Sudipta, Das, Amrita, Ali, Nahid |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904331/ https://www.ncbi.nlm.nih.gov/pubmed/20576102 http://dx.doi.org/10.1186/1471-2180-10-181 |
Ejemplares similares
-
IL-4 contributes to failure, and colludes with IL-10 to exacerbate Leishmania donovani infection following administration of a subcutaneous leishmanial antigen vaccine
por: Bhowmick, Sudipta, et al.
Publicado: (2014) -
Combining Cationic Liposomal Delivery with MPL-TDM for Cysteine Protease Cocktail Vaccination against Leishmania donovani : Evidence for Antigen Synergy and Protection
por: Das, Amrita, et al.
Publicado: (2014) -
Correction: Combining Cationic Liposomal Delivery with MPL-TDM for Cysteine Protease Cocktail Vaccination against Leishmania donovani: Evidence for Antigen Synergy and Protection
por: Das, Amrita, et al.
Publicado: (2015) -
Identification of Novel Leishmania donovani Antigens that Help Define Correlates of Vaccine-Mediated Protection in Visceral Leishmaniasis
por: Bhowmick, Sudipta, et al.
Publicado: (2009) -
Potentiating Effects of MPL on DSPC Bearing Cationic Liposomes Promote Recombinant GP63 Vaccine Efficacy: High Immunogenicity and Protection
por: Mazumder, Saumyabrata, et al.
Publicado: (2011)